AstraZeneca

AstraZeneca's COVID prevention drug cuts risk of disease in vulnerable patients
Reuters
Thu, 05/16/24 - 11:26 am
AstraZeneca
sipavibart
COVID-19
Winners and Losers in Biopharma’s Q1 2024 Earnings Season
BioSpace
Wed, 05/15/24 - 11:30 am
earnings
Amgen
AstraZeneca
Novo Nordisk
Biogen
Bristol Myers Squibb
JNJ
Big Pharma’s most improved drugs: a new generation of blockbusters
Pharma Voice
Tue, 05/14/24 - 11:34 am
Big Pharma
Eli Lilly
Mounjaro
Novo Nordisk
Wegovy
JNJ
Tecvayli
Merck
Vaxneuvance
AbbVie
Qulipta
AstraZeneca
Saphnelo
Novartis
Leqvio
Roche
Genentech
Vabysmo
Amgen
Evenity
Pfizer
Vyndaqel
As Bristol Myers reveals trial failure, AstraZeneca's Imfinzi stays king in stage 3 lung cancer
Fierce Pharma
Mon, 05/13/24 - 11:20 am
Bristol Myers Squibb
Opdivo
Yervoy
clinical trials
non-small cell lung cancer
AstraZeneca
Imfinzi
Pfizer and AstraZeneca announce new investments of nearly $1 billion in France
Reuters
Mon, 05/13/24 - 11:17 am
Pfizer
AstraZeneca
France
AZ oncology chief says AI can help solve cancer’s ‘ZIP code lottery’ as health disparities persist
Pharma Voice
Wed, 05/8/24 - 11:25 am
AstraZeneca
oncology
artificial intelligence
R&D
AstraZeneca to withdraw COVID-19 vaccine globally, Telegraph reports
Reuters
Tue, 05/7/24 - 06:26 pm
AstraZeneca
COVID-19
vaccines
AstraZeneca Invests $140M in Cellectis, Secures 44% Stake in CAR-T Specialist
BioSpace
Mon, 05/6/24 - 11:41 am
AstraZeneca
Cellectis
CAR-T
oncology
allogeneic cells
As Imbruvica bows out, AstraZeneca clinches early Calquence win in newly diagnosed MCL
Fierce Pharma
Thu, 05/2/24 - 11:31 am
AbbVie
JNJ
Imbruvica
AstraZeneca
Calquence
mantle cell lymphoma
AstraZeneca and Daiichi Sankyo’s Enhertu shows promise in breast cancer trial
Clinical Trials Arena
Mon, 04/29/24 - 11:12 am
AstraZeneca
Daiichi Sankyo
Enhertu
breast cancer
HER2-low breast cancer
Why the obesity drug market is about to get a lot more crowded
Medical Marketing and Media
Fri, 04/26/24 - 11:49 am
obesity
Novo Nordisk
Wegovy
Eli Lilly
Zepbound
Roche
AstraZeneca
Sanofi and AstraZeneca Scrap Several Early-Stage Programs in Q1
BioSpace
Thu, 04/25/24 - 05:56 pm
Sanofi
AstraZeneca
AstraZeneca leaps after smashing first-quarter forecasts
Reuters
Thu, 04/25/24 - 11:42 am
AstraZeneca
earnings
AstraZeneca’s Lynparza to remain dominant in PARP inhibitors market with $4 billion in sales by 2027
Biopharma Reporter
Thu, 04/25/24 - 11:36 am
AstraZeneca
PARP inhibitors
Merck
Lynparza
ovarian cancer
AstraZeneca’s Tagrisso maintains momentum in NSCLC with FLAURA2 results
Clinical Trials Arena
Fri, 04/19/24 - 11:26 am
AstraZeneca
non-small cell lung cancer
Tagrisso
Biopharma M&A more than doubled in the first quarter compared to the year prior: report
Fierce Biotech
Thu, 04/18/24 - 11:11 am
M&A
biotech
AstraZeneca
Merck
Gracell
Harpoon Therapeutics
AstraZeneca Expands Fasenra’s Label to Younger Children with Severe Asthma
BioSpace
Fri, 04/12/24 - 11:15 am
AstraZeneca
Fasenra
severe asthma
FDA
eosinophilic asthma
pediatric
Shareholders approve AstraZeneca's 2024 pay proposal for CEO Pascal Soriot despite proxy adviser discontent
Fierce Pharma
Fri, 04/12/24 - 11:01 am
AstraZeneca
Pascal Soriot
Pharma CEOs
executive compensation
Leading AstraZeneca investor defends CEO pay ahead of shareholder vote
Fierce Pharma
Wed, 04/10/24 - 05:47 pm
AstraZeneca
Pascal Soriot
Pharma CEOs
executive compensation
7 Billion-Dollar Oncology M&As from Q1
BioSpace
Wed, 04/10/24 - 11:24 am
oncology
M&A
AbbVie
Immunogen
Bristol Myers Squibb
Mirati Therapeutics
RayzeBio
Novartis
MorphoSys
AstraZeneca
Fusion Pharmaceuticals
JNJ
Ambrx
Gracell

Pages